ClassID:

93455

C07C311/41 - CPC Classification

Classification description:

Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups

Recent Application in this class:
#1
20240286994
2024-08-29

NOVEL SQUARAMIDE DERIVATIVE AND USE THEREOF

#2
20220098148
2022-03-31

Antibiotic ammonium compounds and methods for the treatment of bacterial infections

#3
20180127598
2018-05-10

UV cured benzophenone terminated quaternary ammonium antimicrobials for surfaces

#4
20170198006
2017-07-13

PRMT5 INHIBITORS AND USES THEREOF

#5
20170008839
2017-01-12

Benzende sulfonamide derivatives as HIV integrase inhibitors

#6
20160075643
2016-03-17

NOVEL PROCESS TO PREPARE INTERMEDIATES OF HIV-PROTEASE INHIBITORS THEREOF

#7
20150018523
2015-01-15

Unnatural reactive amino acid genetic code additions

#8
20140170067
2014-06-19

Ligands for targeting of S1P receptors for in vivo imaging and treatment of diseases

#9
20140018326
2014-01-16

Sulfonamides as HIV protease inhibitors

#10
20140018325
2014-01-16

HIV protease inhibitors

#11
20130158261
2013-06-20

Protease inhibitors

#12
20130023463
2013-01-24

HIV protease inhibiting compounds

#13
20120004183
2012-01-05

Unnatural reactive amino acid genetic code additions

#14
20110021448
2011-01-27

Inhibitors for the soluble epoxide hydrolase

#15
20110003827
2011-01-06

HIV protease inhibiting compounds

#16
20100234456
2010-09-16

Biaryl carboxylic acid apoptosis promoters

#17
20100184974
2010-07-22

Protease inhibitors

#18
20100093811
2010-04-15

HIV PROTEASE INHIBITORS

#19
20100048950
2010-02-25

Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof

#20
20100022601
2010-01-28

Sulfonamide compounds and use thereof

#21
20090023664
2009-01-22

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#22
20080318255
2008-12-25

Fluorescent Labeled Sphingosines

#23
20070135392
2007-06-14

Apoptosis promoters

#24
20070082883
2007-04-12

HIV protease inhibitors

#25
20070078173
2007-04-05

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#26
20060276493
2006-12-07

α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#27
20060270609
2006-11-30

Inhibitors for the soluble epoxide hydrolase

#28
20060246509
2006-11-02

Unnatural reactive amino acid genetic code additions

#29
20060166990
2006-07-27

Aminobenzophenone compounds

#30
20060128634
2006-06-15

Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors

#31
20050267171
2005-12-01

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#32
20050032889
2005-02-10

Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same